Brown Christopher D. sold $328K of MASS

Brown Christopher D. sold 30,000 shares of 908 Devices Inc. (MASS) at $10.95 ($0.33M total) on 2026-11-04 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Brown Christopher D.
Published Nov 6, 2026, 9:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 6, 2026, 9:33 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$MASS
Neutral
medium confidence
Mentioned
$MASS
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$MASSNeutralLow
01

Why it matters

Insider sales can influence short-term sentiment, especially when a director is involved.

02

Market read

A modest insider sale by a director may cause slight bearish pressure but is unlikely to move the stock materially.

03

What to watch

Potential upcoming corporate actions or financing needs not disclosed.

Relevance 3/10Novelty 3/10Timing: post-market filing on 2026-11-06

Background

SEC Form 4 filing discloses insider transactions for public companies.

Company-level read

Ticker impact

$MASSNeutralMedium confidence
Context

Director Brown Christopher D. sold 30,000 shares for $328,500 via a 10b5-1 plan, reducing his stake to 775,559 shares.

Expected impact

likely slight downward pressure as the market prices the insider sell.

Evidence & confidence

Form 4 filings are primary source; the amount is modest but the director role adds relevance.

Market effects

Minimal impact on the broader semiconductor equipment sector.

No significant regional effect.

Limited to investors tracking insider activity.

Counterpoint

The sale could be routine liquidity without negative implications for the company.

Key entities

  • Brown Christopher D.

    Director of 908 Devices Inc.

  • 908 Devices Inc.

    Issuer of the securities, ticker MASS.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$MASSMed

908 Devices Q3 2026 slides: 35% growth, raised guidance

908 Devices (NASDAQ:MASS) reported 35% YoY revenue growth to $19.0M in Q3 2026, raising full-year guidance to $68.5M-$70.0M. Shares fell 4.43% premarket. The company focuses on chemical detection tools for public safety and defense, with FTIR products contributing 55% of revenue. Despite narrowing losses, concerns remain over customer concentration and adjusted EBITDA losses.

$MASSMed

908 Devices Reports Third Quarter 2026 Financial Results and Achieves Record Revenue

908 Devices Inc. (MASS) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 ​ ​ 908 Devices Reports Third Quarter 2026 Financial Results and Achieves Record Revenue Revenue increased 35% compared to prior year Raises low end of 2026 revenue outlook ​ ​ BURLINGTON, Mass. – November 10, 2026 – 908 Devices Inc. (Nasdaq: MASS), a core small-cap

$MASSMed

908 Devices Inc. Q2 2026 Earnings Call Summary

908 Devices reported Q2 2026 revenue up 23%, driven by U.S. state and local demand for fentanyl and synthetic drug detection. VipIR saw 35+ shipments, and the NIRLAB acquisition added an AI subscription model. Full-year 2026 revenue guidance was raised to $68m-$70m. Adjusted EBITDA loss narrowed 50% YoY; recurring revenue target is 30%+.

$MASSMedAI 8/10

908 Devices Q2 Earnings Call Highlights

908 Devices (NASDAQ: MASS) reported Q2 operating expenses of $21.2M, down from $21.5M, and narrowed net loss from continuing operations to $11.9M. Adjusted EBITDA loss improved to $1.9M. Cash and marketable securities were $101.5M with no debt. The company raised 2026 revenue guidance to $68M-$70M and expects recurring revenue of $4.9M (31%).

$MASSMed

908 Devices Reports Second Quarter 2026 Financial Results and Raises Low End of 2026 Revenue Outlook

908 Devices Inc. (MASS) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 ​ ​ 908 Devices Reports Second Quarter 2026 Financial Results and Raises Low End of 2026 Revenue Outlook Revenue increased 23% compared to prior year Updated full year 2026 outlook reflects 21% to 25% year-over-year growth ​ BURLINGTON, Mass. – August 11, 2026 – 908